Montréal Invivo
  • Business Directory
  • Newsletters
  • Events
  • News
  • FR
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Artificial Intelligence
      • Digital health
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become partners
  • Home
  • Business Directory
  • Newsletters
  • Events
  • News
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Artificial Intelligence
      • Digital health
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become partners
  • FRANçAIS
Back to documents
Other documents

On PMPRB reform, political leadership and evidence-based approach needed

17 Apr 2019

A letter sent to the Prime Minister of Canada, co-signed by Jason Field, President & CEO of Life Sciences Ontario, Frank Béraud, President & CEO of Montréal InVivo and Mel Wong, President & CEO of BioAlberta.

Response-to-PMO-Apr-17-19 - 0,61 MB
Documents

We suggest

11 Aug 2016
Briefs and consultations

Consultations sur l’agenda d’innovation du Canada – Survol des recommandations

Instaurer une société entrepreneuriale et créatrice Appuyer l’excellence scientifique à l’échelle mondiale Développer des grappes et des partenariats de calibre mondi...

03 Sep 2020
Briefs and consultations

Mémoire présenté dans le cadre des consultations relatives aux lignes directrices du CEPMB de juin 2020

Une lettre rédigée par BIOQuébec, Québec International et Montréal InVivo, trois organisations qui représentent ensemble la quasi-totalité des acteurs et des intervenants...

18 May 2022
Briefs and consultations

Presentation of the Rare Disease Strategic Action Plan 2022

Montreal InVivo has created a Rare Disease Project Committee, representing the entire ecosystem, to propose a national plan! The presentation highlights the need for rare diseas...

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters

I want to subscribe
Montréal Invivo
  • Press releases
  • Newsletters
  • Contact us
  • Privacy policy
514 987-9377
info@montreal-invivo.com
630 rue Sherbrooke Ouest, bureau 460, Montreal (Québec), H3A 1E4
All rights reserved 2025 Montréal Invivo Creation and Web Design PAR Design
×
facebook twitter X home map-marker map refresh clock chevron-left chevron-up chevron-right chevron-down angle-left angl-right angle-up angle-down angle-left angle-right angle-up angle-down fax phone book search envelope-o lock print play book calendar user share2 linkedin cloud-download youtube-play spinner calendar doc pdf svg